Genelux Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$3.01

+0.11 (+3.79%)

As of Jun 30, 10:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +78.4% upside

Low Target $3.28

Average Target $5.37

High Target $6.50

Current Price $3.01

Current
$3.01

Target
$5.37

$3.28 $5.37 avg $6.50

Scenario Analysis

Bear Case

$3.28

9.0%

Low target

Base Case

$5.37

+78.4%

Avg target

Bull Case

$6.50

+115.9%

High target

Risk/Reward

12.9x

Highly favorable

Price in Context

52-Week High

$8.54

-64.7% from high

52-Week Low

$2.29

+31.4% from low

Target vs 52W High

$5.37

-37.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%